吉祥坊登录

Shanghai, China - MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") was recently listed as "2017 Shanghai Patent Affairs Pilot Enterprise" by Shanghai Intellectual Property Administration and will receive fund from Shanghai government and Pudong district government. Shanghai Intellectual Property Administration started to accept applications of patent demonstration/pilot enterprises since February and selected 95 companies as "2017 Shanghai Patent Affairs Pilot Enterprises" after expert review, group discussion, and authority approval.

Since its establishment, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") has built a complete intellectual property management system based on its operation strategy, to manage intellectual property globally, control and prevent risks in infringement of intellectual property rights, as well as to realize strategic intellectual property application and management. With the same strategic goal as MicroPort®, MicroPort® Endovascular continues to carry out technology innovation and increase the awareness of its brand, and meanwhile, under the guidance of its parent company, it successfully established its own intellectual property management system which was granted China’s qualification certificate. MicroPort® Endovascular has done an outstanding job in patent invention, implementation, protection and management. Up to date, it applied for 120 patents, in which, 84 are Chinese patents, 15 are PCT patents, and 21 are overseas patents, and 82.5% of the applied patents are invention patents. At the same time, it gained 53 authorized patents.

Aside from MicroPort® Endovascular, another subsidiary of MicroPort® - Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort®EP") – was also listed as "Shanghai Patent Affairs Pilot Enterprise" in 2015. In the future, MicroPort® and its subsidiaries will continue to enhance the intellectual property management systems and patent data platforms to promote the industrialization of patented technologies, improve the efficiency in patent invention, application, protection and management, so as to translate patents into economic and social benefits.